Hypofractionated radiotherapy with concurrent temozolomide chemotherapy in patients with newly diagnosed RPA class V glioblastoma multiforme: promising early results
Conclusion
The HFRT/TMZ regimen was safe, well tolerated, and convenient for GBM patients with the poorest prognosis, rendering a shorter overall treatment time and no increase in toxicity.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Dexamethasone | Hematology | Radiation Therapy | Study | Temodar | Toxicology